Oct 06, 2020

LyseNTech signed an NDA with CHA Vaccine Institute and launched a joint research on the development of phage-based COVID-19 vaccine.

CHA Vaccine Institute is a research-oriented biotechnology company focused on the prevention and treatment of infectious diseases as well as chronic disease.